Helping stimulant-using men at high risk for HIV reduce substance use and HIV risk
Reducing co-occurring substance use and HIV risk among stimulant-using men at high risk for HIV in the United States of America.
This project aims to create and test a personalized program for men who use stimulants and are at high risk for HIV, helping them reduce both substance use and their chances of getting HIV.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Florida NIH-funded |
| Lab location | 1 site (Gainesville, United States) |
| Project ID | NIH-11086647 on NIH RePORTER |
What this research studies
We are developing a specialized program designed for men who use stimulants and face a high risk of HIV infection. This program will address social and behavioral factors, as well as personal networks, that influence stimulant use and HIV risk. Our goal is to create a tailored approach that can help reduce stimulant use, decrease unsafe sexual practices, and encourage the use of HIV prevention medications like PrEP. We plan to test how well this program works and if it is acceptable to participants through a carefully designed study.
Who could benefit from this research
Good fit: Ideal candidates for future participation would be men in the United States who use stimulants and are identified as being at high risk for HIV.
Not a fit: Patients who do not use stimulants or are not at high risk for HIV may not directly benefit from this specific intervention.
Why it matters
Potential benefit: If successful, this program could help men at high risk for HIV reduce their stimulant use and significantly lower their chances of contracting HIV and other sexually transmitted diseases.
How similar studies have performed: While the specific tailored intervention is new, behavioral interventions have shown success in addressing substance use and HIV risk in other populations.
Where this research is happening
Gainesville, United States
- University of Florida — Gainesville, United States (Active)
Researchers
- Principal investigator: Colon-Burgos, Jose Felix — University of Florida
- Study coordinator: Colon-Burgos, Jose Felix
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.